Molina Healthcare Inc.
Income Statement
| Line Item | Jul 2025 | Jun 2025 | Apr 2025 | Mar 2025 | Feb 2025 | Dec 2024 | Oct 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $11.43B | — | $11.15B | — | — | — | $10.34B |
| Cost of Revenue | — | $9.83B | — | $9.48B | — | — | — | $8.64B |
| Gross Profit | — | $1.60B | — | $1.67B | — | — | — | $1.70B |
| Gross Margin | — | 14.0% | — | 15.0% | — | — | — | 16.4% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $711.0M | — | $774.0M | — | — | — | $676.0M |
| Operating Income | — | $373.0M | — | $433.0M | — | — | — | $467.0M |
| Operating Margin | — | 3.3% | — | 3.9% | — | — | — | 4.5% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $325.0M | — | $390.0M | — | — | — | $438.0M |
| Income Tax Expense | — | $70.0M | — | $92.0M | — | — | — | $112.0M |
| Net Income | — | $255.0M | — | $298.0M | — | — | — | $326.0M |
| Net Margin | — | 2.2% | — | 2.7% | — | — | — | 3.2% |
| EPS (Basic) | — | $4.75 | — | $5.47 | — | — | — | $5.67 |
| EPS (Diluted) | — | $4.75 | — | $5.45 | — | — | — | $5.65 |
| Shares Outstanding (Basic) | 54.2M | 53.6M | 54.2M | 54.6M | 55.5M | 56.0M | 57.2M | 57.6M |
| Shares Outstanding (Diluted) | 54.2M | 53.7M | 54.2M | 54.8M | 55.5M | 56.0M | 57.2M | 57.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |
Abnormally good or abnormally bad conditions do not last forever.